Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Blood (2015) 126 (23): 863.

https://doi.org/10.1182/blood.V126.23.863.863

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Norbert Claude Gorin, Pr, MD PhD, Myriam Labopin, MD, Tomasz Czerw, MD, Kurt Leibundgut, MD, Didier Blaise, MD PhD, Pierre Yves Dumas, MD PhD, Damir Nemet, MD PhD, William Arcese, MD, Roberto Foa, MD, Wu Depei, MD, Anne Huynh, MD, Tsila Zuckerman, MD, Ellen Meijer, MDPhD, Seckin Cagirgan, PhD MD, Jan Cornelissen, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 926.

https://doi.org/10.1182/blood.V126.23.926.926

Published: 2015

Journal Articles

Reduced-Intensity Versus Myeloablative Conditioning for Unrelated Cord Blood Transplantation in Adults with Acute Leukemia: A Report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy & Immunobiology Working Party of the European Group for Blood and Marrow Transplantation

Blood (2015) 126 (23): 155.

https://doi.org/10.1182/blood.V126.23.155.155

Published: 2015

Journal Articles

Autologous HSCT for Ph-Positive Adult Acute Lymphoblastic Leukemia: A Curative Option in the Era of Tyrosine Kinase Inhibitors? an Analysis From the Acute Leukemia Working Party of the EBMT

Sebastian Giebel, MD, Myriam Labopin, Norbert Claude Gorin, Pr, MD, PhD, Denis Caillot, MD, Thibaut Leguay, Nicolaas Schaap, MD, PhD, Mauricette Michallet, MD, PhD, Gerard Socie, MD, Pr, Mohamad Mohty

Blood (2012) 120 (21): 233.

https://doi.org/10.1182/blood.V120.21.233.233

Published: 2012

Journal Articles

Lenalidomide Consolidation Followed by Maintenance After Autologous Transplantation for Multiple Myeloma Decreases Thymic Output and Terminally Differentiated CD4 and CD8 T Cells but Increases Treg

Emmanuel Clave, PhD, Corinne Douay, Tereza Coman, Marc Busson, PhD, Caroline Bompoint, Helene Moins, Maryvonnick Carmagnat, Norbert Claude Gorin, Pr, MD, PhD, Dominique Charron, PhD, Antoine Toubert, MD, PhD, Laurent Garderet, MD

Blood (2012) 120 (21): 4046.

https://doi.org/10.1182/blood.V120.21.4046.4046

Published: 2012

Journal Articles

Inhibition of T Lymphocyte (TL) Proliferation by Mesenchymal Stem Cells (MSCs): Role of Cell Contact between MSCs and TL, Role of MSCs Dose Effect, and Role of Soluble Factors and Adhesion Molecules Expressed by MSCs.

Aisha Nasef, MD, Alain Chapel, PhD, Morad Benshidom, PhD, Yizhuo Zang, MD, Christelle Mazurier, Sandrine Bouchet, Manuel Lopez, PhD, Norbert Claude Gorin, Pr, Dominique Thierry, PhD, Loic Fouillard, MD, PhD

Blood (2004) 104 (11): 4251.

https://doi.org/10.1182/blood.V104.11.4251.4251

Published: 2004

NARROW

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Autologous HSCT for Ph-Positive Adult Acute Lymphoblastic Leukemia: A Curative Option in the Era of Tyrosine Kinase Inhibitors? an Analysis From the Acute Leukemia Working Party of the EBMT

Lenalidomide Consolidation Followed by Maintenance After Autologous Transplantation for Multiple Myeloma Decreases Thymic Output and Terminally Differentiated CD4 and CD8 T Cells but Increases Treg

Inhibition of T Lymphocyte (TL) Proliferation by Mesenchymal Stem Cells (MSCs): Role of Cell Contact between MSCs and TL, Role of MSCs Dose Effect, and Role of Soluble Factors and Adhesion Molecules Expressed by MSCs.

Email alerts

ASH Publications

American Society of Hematology

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Autologous HSCT for Ph-Positive Adult Acute Lymphoblastic Leukemia: A Curative Option in the Era of Tyrosine Kinase Inhibitors? an Analysis From the Acute Leukemia Working Party of the EBMT

Lenalidomide Consolidation Followed by Maintenance After Autologous Transplantation for Multiple Myeloma Decreases Thymic Output and Terminally Differentiated CD4 and CD8 T Cells but Increases Treg

Inhibition of T Lymphocyte (TL) Proliferation by Mesenchymal Stem Cells (MSCs): Role of Cell Contact between MSCs and TL, Role of MSCs Dose Effect, and Role of Soluble Factors and Adhesion Molecules Expressed by MSCs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only